Mepacrine Flow Cytometry Assay for the Diagnosis of Platelet δ-granule Defects: Literature Review on Methods—Towards a Shared Detailed Protocol
Thrombosis and Haemostasis · 01.07.2025 · 125 (07) · 618-633
DOI: 10.1055/a-2413-2870 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.07.2025. Verfasst von Mehdi Khourssaji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Hematology Laboratory, CHU UCL Namur, Yvoir, Belgium. Hauptthemen laut MEDLINE: Flow Cytometry, Blood Platelets, Platelet Function Tests, Blood Platelet Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Accurate assessment of platelet secretion is essential for the diagnosis of inherited or acquired platelet function disorders and more specifically in identifying δ-storage pool disease. Mepacrine, a fluorescent dye, specifically accumulates in platelet δ-granules. The mepacrine flow cytometry (mepacrine FCM) assay has been used for more than half a century in the clinical laboratory as a diagnostic tool for platelet δ-granule disorders. The assay requires a small volume of blood, can be performed in thrombocytopenic patients, provides rapid assessment of δ-granule content and secretion, and, thus, enables differentiation between storage and release defects. There is however a broad heterogeneity in methods, reagents, and equipment used. Lack of standardization and limited data on analytical and clinical performances have led the 2022 ISTH SSC (International Society on Thrombosis and Haemostasis Scientific and Standardization Committee) Subcommittee on Platelet Physiology expert consensus to rate this assay as simple but of uncertain value. Yet, the data used by experts to formulate the recommendations were not discussed and even not mentioned. Guidance for laboratory studies of platelet secretion assay would be very helpful for clinical laboratories and health authorities especially considering the implications of the new In Vitro Diagnostic Regulation in Europe. The purpose of the present work was to review the reported methodologies for the mepacrine FCM assay and to offer an example of detailed protocol. This would help standardization and pave the way for more rigorous comparative studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Hematology Laboratory, CHU UCL Namur, Yvoir, Belgium.
- Institut de Recherche Expérimentale et Clinique (IREC) - Pôle Mont, Université catholique de Louvain, Yvoir, Belgium.
- Division of Haematology and Central Haematology Laboratory, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
- Service d'Hématologie Biologique, Hôpital Necker AP-HP, Paris, France.
- Centre de Ressources et de Compétences - Maladies Hémorragiques Constitutionnelles, CHU de Nantes, Nantes, France.
- CRC2INA, Université de Nantes, Nantes, France.
ORCID-Profile: Lorenzo Alberio
Zitieren
APA
Khourssaji, M., Bareille, M., Alberio, L., Borgel, D., Fouassier, M., Béné, M. C., Lecompte, T., & Mullier, F. (2025). Mepacrine Flow Cytometry Assay for the Diagnosis of Platelet δ-granule Defects: Literature Review on Methods—Towards a Shared Detailed Protocol. Thrombosis and Haemostasis, 125(07), 618-633. https://doi.org/10.1055/a-2413-2870
Vancouver
Khourssaji M, Bareille M, Alberio L, Borgel D, Fouassier M, Béné MC, et al. Mepacrine Flow Cytometry Assay for the Diagnosis of Platelet δ-granule Defects: Literature Review on Methods—Towards a Shared Detailed Protocol. Thrombosis and Haemostasis. 2025;125(07):618-633. doi:10.1055/a-2413-2870
BibTeX
@article{Khourssaji2025,
author = {Khourssaji, Mehdi and Bareille, Marion and Alberio, Lorenzo and Borgel, Delphine and Fouassier, Marc and Béné, Marie-Christine and Lecompte, Thomas and Mullier, François},
title = {Mepacrine Flow Cytometry Assay for the Diagnosis of Platelet δ-granule Defects: Literature Review on Methods—Towards a Shared Detailed Protocol},
journal = {Thrombosis and Haemostasis},
year = {2025},
volume = {125},
number = {07},
pages = {618--633},
doi = {10.1055/a-2413-2870}
}
EUVIMED